ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,354Medicare Part D Prescriptions Filled, Including Refills

Rank: 416 out of 3647

$763K Total Retail Price of All Prescriptions

Rank: 464 out of 3647

646 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 646 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 646 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 13,605 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 835 735 1 2
SIMVASTATIN 808 752 2 1
HYDROCHLOROTHIAZIDE 670 574 3 9
LISINOPRIL 510 449 4 4
METFORMIN HCL 489 425 5 6
LOSARTAN POTASSIUM 488 471 6 11
OMEPRAZOLE 434 404 7 3
LOVASTATIN 383 347 8 21
NIFEDIPINE ER 307 267 9 67
IBUPROFEN 305 251 10 55
ATENOLOL 275 234 11 10
TEMAZEPAM 236 215 12 47
CARVEDILOL 225 206 13 20
NIFEDIAC CC 221 204 10 14 325
HYDRALAZINE HCL 217 199 15 81
MELOXICAM 211 195 16 33
CLONIDINE HCL 211 190 16 46
FUROSEMIDE 207 197 18 8
METOPROLOL SUCCINATE 204 181 19 18
LOSARTAN-HYDROCHLOROTHIAZIDE 197 170 20 48
GLIMEPIRIDE 195 179 21 45
ENALAPRIL MALEATE 195 166 21 35
INSULIN SYRINGE 186 151 23 76
GABAPENTIN 168 130 24 17
ALENDRONATE SODIUM 166 153 25 23
DIOVAN 163 161 26 40
RANITIDINE HCL 157 141 27 29
DIOVAN HCT 157 154 27 80
POTASSIUM CHLORIDE 147 127 29 24
VENTOLIN HFA 146 133 30 88
TAMSULOSIN HCL 146 141 30 28
METOPROLOL TARTRATE 146 134 30 7
NAPROXEN 144 128 33 70
LANTUS 143 131 34 59
ACETAMINOPHEN-CODEINE 141 108 S3 35 149
TRAMADOL HCL 137 93 36 22
ALLOPURINOL 122 104 37 37
VIAGRA 121 102 38 69
CRESTOR 111 108 39 19
GLYBURIDE-METFORMIN HCL 110 106 R 40 94
DOXAZOSIN MESYLATE 108 108 41 57
GLYBURIDE 101 83 R 42 54
AZITHROMYCIN 99 92 43 34
TRIAMTERENE-HCTZ 94 75 44 58
PANTOPRAZOLE SODIUM 87 75 45 38
CLOTRIMAZOLE-BETAMETHASONE 87 78 45 84
FINASTERIDE 86 83 47 66
LEVEMIR 84 71 48 187
DICLOFENAC SODIUM 83 64 49 86
NABUMETONE 82 81 50 262
FLUTICASONE PROPIONATE 79 59 51 32
LABETALOL HCL 78 68 52 172
ATORVASTATIN CALCIUM 74 62 53 13
WARFARIN SODIUM 73 70 54 15
BUMETANIDE 68 68 55 134
NAMENDA 66 60 56 49
TRAMADOL HCL-ACETAMINOPHEN 65 59 57 152
JALYN 63 63 58 332
NOVOLOG MIX 70-30 63 52 58 261
KLOR-CON 10 62 62 60 106
CLOPIDOGREL 61 55 61 26
CIPROFLOXACIN HCL 60 51 62 53
ISOSORBIDE MONONITRATE ER 59 55 63 56
PRAVASTATIN SODIUM 59 55 63 16
LEVOTHYROXINE SODIUM 59 49 63 5
PLAVIX 59 48 63 39
SYMBICORT 58 47 67 153
HUMALOG MIX 75-25 57 38 68 374
CYMBALTA 57 40 68 79
GLIPIZIDE 54 47 70 41
MEGESTROL ACETATE 54 44 R 70 138
MECLIZINE HCL 51 51 72 85
SERTRALINE HCL 50 40 73 27
ADVAIR DISKUS 50 48 73 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.